Financials
- Market Capitalization 6.51 M
- Employee 6
- Founded 2016
- CEO N/A
- Website www.alzamend.com
- Headquarter Delaware, United States
- FIGI BBG00ZMXG7M8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.43
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4754 | SKYE Skye Bioscience, Inc. - Common Stock | 1.58 USD | 0.00% | -2.47% | -21.78% | +97.50% | 7.00 M USD | ||
| 4761 | LGVN Longeveron Inc. - Class A Common stock | 2.16 USD | -11.84% | -7.30% | -68.65% | +278.09% | 6.89 M USD | ||
| 4773 | FBLG FibroBiologics, Inc. - Common Stock | 0.96 USD | -4.00% | -17.24% | -38.06% | +128.57% | 6.39 M USD | ||
| 4775 | ACXP Acurx Pharmaceuticals, Inc. - Common Stock | 1.20 USD | -6.25% | -9.09% | -13.67% | -37.50% | 6.32 M USD |